Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Net Income

Aquestive Therapeutics Inc Net Income Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Net Income from 2006 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Net Income for the last 12 months ending December 12, 2018 was $-61m a 90.44% decrease of -56m year over year
  • Aquestive Therapeutics Inc Annual Net Income for 2018 was $-61m a 81.39% decrease of -50m from 2017
  • Aquestive Therapeutics Inc Annual Net Income for 2017 was $-11m a -4.56% increase of 1m from 2016
  • Aquestive Therapeutics Inc Annual Net Income for 2016 was $-12m a -6.76% increase of 1m from 2015
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Net Income Data

12/2018$-14m
09/2018$-15m
06/2018$-36m
03/2018$4m
12/2017$-11m
09/2017$8m
06/2017$-6m
03/2017$-1m
06/2007$-4m
03/2007$-4m

Annual AQST Net Income Data

2018$-61m
2017$-11m
2016$-12m
2006$-13m
2005$-8m
2004$-4m